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Abstract Adhesion and migration are integrated cell
functions that build, maintain and remodel the multicellular
organism. In migrating cells, integrins are the main
transmembrane receptors that provide dynamic interactions
between extracellular ligands and actin cytoskeleton and
signalling machineries. In parallel to integrins, other
adhesion systems mediate adhesion and cytoskeletal cou-
pling to the extracellular matrix (ECM). These include
multifunctional cell surface receptors (syndecans and
CD44) and discoidin domain receptors, which together
coordinate ligand binding with direct or indirect cytoskel-
etal coupling and intracellular signalling. We review the
way that the different adhesion systems for ECM compo-
nents impact cell migration in two- and three-dimensional
migration models. We further discuss the hierarchy of these
concurrent adhesion systems, their specific tasks in cell
migration and their contribution to migration in three-
dimensional multi-ligand tissue environments.
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Introduction
Cell adhesion and migration are fundamental to the
formation and maintenance of multicellular organisms. Cell
adhesion is provided by adhesion molecules, which are
expressed at the cell surface of all nucleated cells, mediate
extracellular binding to cell and tissue substrates and transmit
mechanical docking to the intracellular actomyosin or
intermediate filament cytoskeleton. Cell adhesion underlies
many important physiological processes, including cell
spreading, polarity, anchoring and differentiation. When cell-
tissue interactions undergo dynamic turn-over, adhesion
molecules further mediate cell migration and positioning
duringdynamic phasesofthe body,including morphogenesis,
wound healing and, in a de-regulated form, during cancer
invasion and metastasis (Hood and Cheresh 2002;H y n e s
2002). Likewise, cell adhesion and migration underlie many
functions of the immune system, including leukocyte
recirculation, pathogen recognition and effector function
(Friedl and Weigelin 2008).
To fulfil these various tasks in the different cell types
and tissue contexts, diverse sets of adhesion receptors
contribute to cell interaction with tissue components and to
migration. Adhesion receptor ligands are another cell, a
multimeric particle or macromolecules that are immobilized
in the tissue, such as extracellular matrix (ECM) ligands.
Important ECM proteins recognized by adhesion receptors
are collagens, fibronectin, vitronectin, fibrinogen and
laminin (van der Flier and Sonnenberg 2001). Non-protein
ECM ligands comprise proteoglycan polysaccharides, such
as heparan sulphate, chondroitin sulphate and keratin
sulphate, and the non-proteoglycan polysaccharide hyalur-
onan (Iozzo 1998; Heino and Kapyla 2009).
Several classes of cell surface receptors fulfil adhesion
and cytoskeletal coupling functions and provide a range of
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cell migration (Fig. 1). High affinity adhesion to ECM
ligands is predominantly provided by receptors of the
integrin family (Hynes 2002) and CD44 (Goodison et al.
1999). Whereas integrins predominantly recognize extra-
cellular protein scaffolds, such as interstitial collagen
(Takada et al. 2007), CD44 preferentially binds to extra-
cellular carbohydrate polymers, such as glycoproteins,
glycosaminoglycans and hyaluronic acid (HA; Ponta et al.
2003). In addition to these “classical” adhesion receptors,
other surface receptors can bind ECM components and
induce signalling, including the syndecans (Bernfield et al.
1999) and the receptor tyrosine kinases discoidin domain
receptors (DDRs; Yoshimura et al. 2005). Whereas integrin-
and CD44-mediated adhesions have previously received
substantial attention (Humphries et al. 2003), alternative
adhesion mechanisms and their contribution to cell anchor-
ing and migration have been less well studied. We
summarize here the way that integrin- and non-integrin-
mediated cell-substrate interactions contribute to different
types of cell migration.
Modes of cell migration and adhesion requirements
Cell migration is not a uniform event but comprises distinct
modes of cell migration that are executed by different cell
types and contexts. These migration types vary in cell
shape, adhesion strength and migration speed and also in
whether cell-cell junctions are retained (Fig. 2).
Arguably, the most “simple” migration mode is amoeboid
migration(Friedletal.2001). Cells that move in an amoeboid
manner include primordial germ cells, lymphocytes, dendrit-
ic cells, lymphoma cells and neutrophils, all of which exhibit
low or no integrin-mediated traction force generation
(Entschladen et al. 1997; Friedl et al. 1998;B l a s e re ta l .
2006; Lammermann et al. 2008). These cells form relatively
instable adhesion sites to a substrate; such sites rapidly turn-
over and, depending on extracellular context and signalling,
allow for rapidly adaptive migration (Friedl et al. 2001).
Amoeboid movement is driven by a roundish to ellipsoid cell
shape, non-focalized but rather diffusely organized adhesion
sites to the substrate and a strictly cortical actin cytoskeleton
that lacks stress fibres (Friedl and Wolf 2003). Two types of
Fig. 1 Classes of adhesion
receptors involved in cell adhe-
sion and migration. Important
domains of adhesion receptors
and interstitial ECM ligands
collagen, fibronectin and hya-
luronan are shown
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Based on relatively weak attachment and speading to the
substrate, a fast “gliding” type of movement is enabled that
supports a weakly adhesive pulling-type migration across
two-dimensional (2D) and in three-dimensional (3D) envi-
ronments (Friedl and Wolf 2009). Alternatively, in non-
adhesive cells, polarized dendrite or bleb formation coupled
to rear-retraction fail to attach to 2D substrate and lack
adhesion sites and, thus, provide an intercalating propulsive-
type of migration in 3D tissues (Fackler and Grosse 2008).
The biophysical basis of this blebbing-type migration is
incompletely understood as it shows signs of adhesion-
independent migration. Instead of focalized adhesion com-
plexes, a predominantly cortical actin cytoskeleton drives
cell polarization and physical translocation by shape change
and cytoskeletal stiffness in complex tissue environments
(Paluch et al. 2006; Friedl and Wolf 2009). In cells with
increased adhesion and cytoskeletal contractility, cell-matrix
interactions become focalized and the cell adopts an
elongated spindle-shaped morphology; this mode of migra-
tion is termed mesenchymal migration and is used by
fibroblasts, myoblasts and many cancer cells (Friedl et al.
1998; Friedl 2004), generates substantial adhesion and
traction force towards the surrounding tissue and further
mediates proteolytic tissue remodelling by the function of
cell-produced proteases (Wolf and Friedl 2009). Both ligand
binding and intracellular coupling of cell adhesions are
turned over in the range of minutes to hours thereby
regulating both local adhesion strength and the dynamics of
the cell (Zamir and Geiger 2001;B a l l e s t r e me ta l .2001).
During morphogenesis, regeneration and cancer invasion,
cells that retain cell-cell junctions by means of cadherins and
other cell-cell adhesion mechanisms migrate collectively
either as monolayer sheets or as 3D strands, sprouts or
isolated clusters (Friedl et al. 2004). Two types of force
generation in collective migration are under discussion at
present, depending on the amount of anterior adhesion and
traction force generation. If one or several front- and mid-row
cells generate adhesion and traction force towards the
substrate, collective migration results from adhesive “pulling”
mediated by adhesion-complexes that connect to the actin
cytoskeleton, similar to mesenchymal movement (Hegerfeldt
et al. 2002; Trepat and Wasserman 2009). This type of
migration is commonly detected in sprouting vessels,
epithelial sheets during wound healing and cancer invasion
(Hegerfeldt et al. 2002; Friedl and Gilmour 2009). A second,
less well understood mode of collective force generation is
multicellular pushing, which is produced by a stable stick-
like stalk and a relatively roundish terminal bud that
protrudes into soft tissue in the absence of apparent force-
generating adhesion complexes (Ewald et al. 2008). Thus,
different cellular and molecular requirements for adhesion
and force generation govern the different types of cell
migration. Whereas, until recently, integrins have received
ample attention and are considered as the main mediators of
adhesion force generation during cell migration, the prom-
igratory functions of non-integrin adhesion systems remain
to be integrated into these concepts of cell movement.
Integrins
Integrins are heterophilic cell adhesion molecules consist-
ing of non-covalently connected α and β chains that
together determine ligand-binding specificity and intracel-
lular coupling (Humphries 2000; Hynes 2002). Based on
ECM/ligand recognition, integrins mediate binding to
laminins (α2β1, α3β1, α6β1, α7β1), fibrillar collagens
(α1β1, α2β1, α3β1, α10β1, α11β1) and Arg-Gly-Asp
(RGD) motifs contained in many ECM proteins (α5β1,
Fig. 2 Various migration
strategies. Dependent on
cell-matrix adhesion strengths
and cell contrctility, force
generation occurs either via
attachment to the ECM substrate
and pulling or by cell propul-
sion. Dependent on the stability
of cell-cell adhesion, cells mi-
grate either individually or
within multicellular strands
(red actin cytoskeleton)
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integrins are the most important cell surface receptors for
cell interactions with ECM structures.
Integrins control the strength and turn-over of cell
interactions with ECM scaffolds (Hynes 1992). After ligand
binding, integrins multimerize in the plasma membrane in a
focalized manner and connect, via intracellular signalling
and adaptor proteins, to the actin cytoskeleton, termed focal
contact or focal adhesion (Burridge and Chrzanowska-
Wodnicka 1996; Zaidel-Bar et al. 2007; Moser et al. 2009).
Alternatively, diffuse integrin distribution devoid of micro-
scopically detectable clustering and focalization of adhesion
site mediates substrate binding and intracellular signalling
(Friedl et al. 1998).
To mediate cell movement, the integrin-mediated cell-
substrate interactions and linkages to the actin cytoskeleton
form and turn-over, the dynamics and polarity of which
determine cell speed and directional persistence. The way
that integrins govern migration type and rates depends upon
net adhesion strength per cell, type of cell-matrix inter-
actions and type of substrate. On 2D ECM substrates,
including collagen, fibronection or vitronectin, integrin-
mediated adhesions are preferentially mediated by α5β1,
αvβ3 and α2β1, respectively (Takada et al. 2007). In
integrin-dependent migration models, the highest velocities
result from an intermediate level of net adhesion strength
allowing both rapid focal contact formation and the
generation of traction forces, which are regulated by the
small GTPase Rho (DiMilla et al. 1991; Beningo et al.
2006) . Accordingly, increasing adhesion to the substrate
slows cells down and favours cell immobilization and
anchoring attributable to delayed rear-retraction. Likewise,
at low net adhesion, migration rates are impaired because of
reduced binding strength and force generation at the leading
edge, resulting in partial or complete loss of migration
(Palecek et al. 1997). The impact of adhesion- and traction
force-dependent integrin functions are commonly estab-
lished in haptokinetic migration across a 2D ligand-coated
substrate, so that some degree of attachment is indispen-
sible for migration (Huttenlocher et al. 1995). This principle
of adhesion-driven migration applies to many, if not all,
actin-associated integrins, notably β1, β2, β3, and β4
integrins (Rabinovitz and Mercurio 1997; Maaser et al.
1999; Vicente-Manzanares et al. 2009). Consequently, both
cell adhesion and migration are impaired by adhesion-
perturbing anti-integrin antibodies or genetic deletion of
integrins so that the cells either round up and partly detach
or completely lose contact to the substrate (Friedl and Wolf
2003). If, however, cells move through a 3D ECM, distinct
physical principles apply because cells are entirely sur-
rounded by ECM and, even after loss of adhesion, continue
to interact passively with the substrate (Friedl and Brocker
2000).
For cells of high integrin availability moving through a
3D ECM, including fibroblasts and certain cancer cells,
integrins mediate adhesive pulling at the leading edge so
that traction force towards the substrate is continually
being generated (Fig. 2;M a a s e re ta l .1999;P e t r i ee ta l .
2009). Consequently, cell elongation and mesenchymal
migration are dependent on integrin-mediated adhesion
and focalization of the actin cytoskeleton to matrix
contacts. The integrin engagement leads to the activation
of focal adhesion kinase, Rho/Rac guanine nucleotide
exchange factors and Rho kinase (ROCK), which together
drive the formation and turn-over of adhesions (Iwanicki
et al. 2008). Following interference with integrin-mediated
adhesion, mesenchymal migration is abrogated and no
alternative adhesion receptors compensate for ablated
integrin-dependent force generation and mesenchymal
migration (Maaser et al. 1999;G r i n n e l l2008, 2009). In
mesenchymal migration, integrin β1o rαvβ3 integrins
cooperate with cell surface proteases, notably matrix
metalloproteinases (MMPs) leading to the generation of
small microtracks bordered by remodelled collagen fibres
(Deryugina et al. 1998;W o l fe ta l .2007). Secondary to
traction force generation, mesenchymal migration leads to
contraction and remodelling of the ECM in vitro and to
wound healing (Cooke et al. 2000;L a r s e ne ta l .2006).
If integrin-mediated traction force is low or negligible,
moving cells utilize the amoeboid migration mode (Fig. 2;
Friedl et al. 2001). Whereas, on 2D surfaces, amoeboid
migration is still dependent on low adhesion mediated by
integrins (Lammermann et al. 2008), amoeboid migration in
3D fibrillar collagen or interstitial tissue in vivo persists
either partly or fully after integrins are blocked by antibody
or are genetically ablated (Friedl et al. 1998; Lammermann
et al. 2008). In integrin-independent amoeboid migration,
the leading edge produces pseudopodia, dendites or
roundish-shaped blebs, all of which are dependent on
cortical actin networks but do not form focalized adhesion
complexes with the ECM substrate (Friedl et al. 1998;
Lammermann and Sixt 2009). The mechanisms underlying
integrin-independent migration are incompletely unterstood
but are best explained by actin forward flow followed by
cell intercalation between matrix pores and gaps and cell
contraction mediated by myosin II to move both the cell
rear and the nucleus forward (Lammermann et al. 2008).
Thus, grossly different magnitudes of integrin-mediated
adhesion and force generation are associated with the
diverse migration modes.
Accordingly, in 3D ECM-based models, cells can switch
between high and low integrin-dependence of migration.
The lowering of integrin-mediated adhesion by blocking
with antibodies or by interfering with the integrin-effector
c-src does not abrogate migration of cancer cells in 3D
ECM-based models but is followed by persistent robust cell
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Whether such plasticity is restricted to cancer cells and
which alternative adhesion mechanisms compensate for
impaired integrin function remain unclear.
Because of their multifunctional nature and ubiquitous
expression, integrins contribute to most cell-tissue interac-
tion models substantially and impact other adhesion path-
ways in response to ECM. Thus, as we will discuss below,
the study of adhesion mechanisms other than integrins is
often compromised by an overlap with integrin-mediated
substrate recognition and function.
Syndecans
Syndecans are a familiy of transmembrane cell surface
heparan sulphate proteoglycans (HSPGs) with four mem-
bers, syndecan 1–4. All vertebrate cells express at least one
syndecan family member in a cell-type and tissue-specific
manner, which is further modified during cell activation
(Tkachenko et al. 2005). Syndecans bind to ECM ligands
and further cooperate with other cell surface receptors for
ligand-binding and signalling. Via their heparin-binding
ectodomain, syndecans bind to extracellular glycosamino-
glycans, including heparan sulphate and chondroitin
sulphate, and to other ECM molecules, including collagen
types I, III and IV, fibronectin and vitronectin (Beauvais et
al. 2004). By distinct mechanisms, syndecans further bind
via residues within the HSPG side chains to cytokines and
growth factors, including fibroblast growth factor-2 and
epidermal growth factor and “present” them laterally to
their specific receptors (Wu et al. 2003; Tkachenko et al.
2005).
Syndecans mediate both cell adhesion and co-signalling,
often in the same context, which renders the distinction
between adhesion and co-signalling function difficult, if not
impossible. In most cell models, overexpression of
syndecans enhances cell adhesion and haptokinetic
migration in normal and neoplastic cells, whereas inter-
ference with syndecan function decreases cell migration
(Table 1). As an example, in endothelial cells, binding of
syndecan-4 to fibronectin-cated substrate results in
syndecan-4 co-clustering with integrin α5β1a n dt h e
activation of Rac-1 through the intracellular scaffold
protein synectin (Tkachenko et al. 2006;M o r g a ne ta l .
2007). Consequently, syndecans enhance cell spreading,
polarization and migration in vitro and cell migration and
tissue remodelling during wound healing and angiogenesis
in vivo (Table 1; Echtermeyer et al. 2001; Stepp et al.
2002; Morgan et al. 2007).
Syndecans interact with a large number of ligands,
which in parallel also bind to other cell surface receptors.
Thus, a functional synergy between syndecans and integrins
leads to an overlap in adhesion-dependent signalling path-
ways (Morgan et al. 2007). Given that syndecans function-
ally synergize with integrins, the extent to which syndecans
can be understood as true adhesion receptors awaits further
clarification by using models that isolate the direct
contribution of syndecans to adhesion from its co-receptor
and signalling activities.
Discoidin domain receptors (DDR)
Discoidin domain receptors (DDRs) belong to the
discoidin-like domain-containing subfamily of receptor
tyrosine kinases, with two members in mammalian cells:
DDR1, expressed as five isoforms (DDR1a-e), and DDR2
with no known isoforms (Alves et al. 2001; Vogel et al.
1997). As main ligands, DDRs bind to all triple-helical
fibrillar collagens, and DDR1 additionally binds to
collagens type IV, VI and VIII (Curat et al. 2001).
DDR1 is expressed in many epithelia (Vogel et al. 1997),
and in tissue-infiltrating leukocytes (Kamohara et al.
2001), whereas DDR2 is expressed in muscle cells,
kidney, lung, brain and connective tissue (Vogel 1999);
both DDRs are upregulated in many cancer cell types
(Vogel et al. 2006). After ligand binding, DDRs induce
various intracellular signalling pathways, including the
activation of Wiskott-Aldrich syndrome protein and Pyk-
2s, the SH2-domain-containing-transforming protein and
SH2-domain-containing phosphatase 2, all of which
indirectly promote actin dynamics (Buday et al. 2002;
Koo et al. 2006;V o g e le ta l .2006). Accordingly, DDRs
enhance cell migration, proliferation, and survival (Vogel
1999). In contrast to other receptor tyrosine kinases, initial
signalling through DDRs occurs within minutes but
peaks only several hours later, implicating DDRs in
sustained and slow rather than acute responses to the
E C M( V o g e le ta l .1997, 2006).
Despite their collagen-binding capability, whether DDRs
can be considered as classical adhesion receptors is unclear.
DDR signalling typically co-engages with integrins (Shintani
et al. 2008). DDRs enhance integrin-mediated cell adhesion
to collagen (Kamohara et al. 2001) and enhance integrin-
mediated signalling (Shintani et al. 2008). In addition, in
some models, DDR1 overexpression enhances cell attach-
ment to collagen that cannot be directly attributed to integrin
function, suggesting either a direct adhesion function of
DDR1 or the coengegement of yet another adhesion system
(Kamohara et al. 2001).
DDRs regulate cell migration in an isoform-specific
manner. DDR1a-overexpressing leukemia and glioma cells
show enhanced migration into 3D collagen lattices, whereas
overexpression of DDR1b reduces migration in both cell
types (Kamohara et al. 2001; Ram et al. 2006). On the basis
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signalling pathways that underlie such different fine-tuning
of migration are unknown.
DDRs not only enhance cytoskeletal dynamics but
further induce a more complex “invasion program”. DDR
signalling upregulates pro-invasive MMPs 2 and 9, which
leads to enhanced proteolytic degradation of ECM (Hou et
al. 2002) and invasion and metastasis of tumour cells in
vivo (Vogel et al. 1997). Although experimental over-
expression of DDR1 acts in a promigratory manner (Ram et
al. 2006), whether lower endogenous levels mediate the
same effect remains unclear. To improve the discrimination
between adhesive and signalling functions of DDRs, future
studies should address DDR adhesion and other functions
in integrin-independent models.
CD44
CD44 is a highly glycosylated member of the hyaladherin
or link protein superfamily of adhesion molecules and is
either expressed as the standard form (CD44s) or as one of
12 distinct isoforms (CD44v1-v12; Ponta et al. 2003; Naor
et al. 2008). CD44 binds its main ligand, HA, via the
hyaluronan-binding domain (Banerji et al. 2007). Other
ligands, which instead interact with variable membrane-
proximal domains of CD44, include heparan sulphate (exon
v3), chondroitin sulphate (exon 5) and, via unmapped sites
with probably weaker binding strength, collagen types I and
VI, fibronectin and laminin and cell surface receptors, such
as E- and L-selectin (Ponta et al. 2003; Bendall et al. 2004;
Naor et al. 2007). The cytoplasmic domain of CD44
recruits the actin-binding proteins ezrin, radixin and moesin
(ERM; Legg et al. 2002) and ankyrin and thereby
physically bridges extracellular ligands to the actin cyto-
skeleton and induces intracellular signalling (Bourguignon
2008; Singleton et al. 2004). In addition to its adhesion
function, CD44 serves as a co-receptor for other signalling
receptors, such as the receptor tyrosine kinase mesenchymal-
epithelial transition factor (c-Met), epidermal growth factor
receptor and tumour growth factor-β (Orian-Rousseau et al.
2002).
CD44s is expressed by all nucleated vertebrate cells,
including most cancer cells (Naor et al. 1997; Tanabe et
al. 1993). Activated cells and many cancer cells addition-
ally express CD44 variants, such as CD44v3-v10 on
keratinocytes and CD44v6 on many transformed cells
((Brown et al. 1991); Wang et al. 2009). CD44-mediated
signalling occurs via various pathways. HA binding leads
to the activation of several effectors, including c-Src
(Ouhtit et al. 2007), Rac1 and RhoA (Bourguignon et al.
2000; Bourguignon et al. 2001). In turn, active Rho and its
effector ROCK promote the recruitment of the
cytoskeleton-protein ankyrin-1 and engage with the con-
served cytoplasmic domain of CD44 and thereby provide a
second link between CD44 and the actin cytoskeleton
(Singleton and Bourguignon 2004).
In addition to binding to tissue-anchored HA, CD44
immobilizes HA at the cell surface (Rilla et al. 2008). In
early cell adhesion, cell-surface-tethered HA captures ECM
substrata prior to integrin-mediated focal contact formation
(Zimmerman et al. 2002). Cell-surface HA is constitutively
Table 1 Regulation of cell migration by syndecans (2D two-dimensional, 3D three dimensional)
Syndecan
type
Cell type Experimental model Function Reference
Syndecan-1 Breast cancer cells 2D spreading and migration assay;
migration through 3D matrigel after
overexpression
Increased spreading, adhesion and
migration on 2D collagen I; increased
cell invasion in 3D Matrigel
Burbach et al. 2004
Myeloma cells In vivo model of experimental
metastasis in mice
Increased metastasis and tumour growth Khotskaya et al. 2009
Syndecan-2 Intestinal
epithelial cells
2D adhesion and migration after
overexpression
Increase of adhesion, spreading on
collagen type I (in cooperation with
α2β1 integrin)
Choi et al. 2009
Colon carcinoma
cells
Migration across type-I-collagen-
coated surface after overexpression
Increased migration speed Park et al. 2002
Melanoma cells Migration through polycarbonate
filter (transwell) after overexpression
Increased migration and invasion Lee et al. 2009
Syndecan-3 Neuronal cells Migration through polycarbonate
filter (transwell)
Increased migration Hienola et al. 2006
Syndecan-4 Melanoma cells Adhesion and migration across
fibronectin-coated 2D surface
Increased adhesion and migration Chalkiadaki et al. 2009
Fibroblasts Adhesion and migration in 3D
fibrin-fibronectin-matrix
Increased adhesion and migration Midwood et al. 2004, 2006
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and lamellipodia, and engages with extracellular ECM
substrate before integrin clustering and the formation of
focal adhesions are detectable (Zimmerman et al. 2002;
Rilla et al. 2008).
In most 2D haptokinetic migration models, CD44
enhances migration, either directly by mediating attachment
to the substrate or by enhancing promigratory signalling. In
normal and neoplastic cells, CD44 supports adhesion and
migration across HA-coated surfaces (Zhu et al. 2006).
Hereby, in contrast to integrins and syndecans, CD44 does
not cluster at contact sites but rather seems to form uniform
interaction zones to the substrate with a trend for
redistribution to the cell rear (Jacobson et al. 1984;
Goebeler et al. 1996; Friedl et al. 1997). In migrating
leukocytes, CD44 is virtually excluded from the leading
edge and accumulates together with ERM proteins in the
posterior uropod, albeit that its function here is unclear
(Sanchez-Madrid and del Pozo 1999; Wagner et al. 2008).
Many cells, irrespective of adhesion strength and the
substrate across which they migrate, release substantial
amounts of CD44, the function of which however is
unclear, from the rear of the cell (Bazil and Horejsi 1992;
Friedl et al. 1997). In addition to an adhesion function, the
CD44-HA interaction results in the rapid activation of
surface proteolysis via endopeptidases, including MT1-
MMP and ADAMs (a disintegrin and metalloproteinase
family), which cleave the CD44 ectodomain and thereby
limit CD44-mediated cell attachment (Nagano et al.
2004). Thus, the dual role of CD44 comprises cell
attachment and the secondary release of CD44-mediated
adhesion bonds.
In contrast to in vitro findings with respect to the
contribution of CD44 to cell migration on an HA
substrate, CD44-deficient mice lack obvious defects of
development, regeneration and immune function, suggest-
ing intact interstitial cell migration (Protin et al. 1999;
Naor et al. 2008). To what extent other adhesion receptors,
including β1 integrins, the receptor for hyaluronan-
mediated motility (RHAMM) or layilin as alternative
receptors for HA compensate for the loss of CD44 remains
to be addressed (Protin et al. 1999;N a o re ta l .2007;C h e n
et al. 2008).
In cancer models, the interaction of CD44 variants with
HA supports lymphoma and melanoma progression and
metastasis, which is prevented by blocking antibodies
targeting CD44v4-v10 or by expressing CD44 with an
inactive HA-binding domain (Wallach-Dayan et al. 2001).
Conversely, over-expression of soluble CD44 ectodomain
in malignant melanoma and mammary carcinoma cells
inhibits growth, local invasion and metastasis in vivo,
suggesting a role for the membrane-anchoring of CD44
(Ahrens et al. 2001; Peterson et al. 2000). However, given
the lack of a phenotype in CD44-deficient mice, the in vivo
relevance of CD44-mediated adhesion and migration
detected in vitro remains unclear. Thus, like syndecans,
CD44 and its variants provide multiple adhesion and co-
signalling functions, the mechanistic contribution of which
to cell migation remains incompletely understood.
Concluding remarks
The various adhesion systems expressed by vertebrate cells
serve overlapping functions for cell positioning, anchoring and
signalling but simultaneously retain additional independent and
unique properties for each receptor. Whereas the molecular
structure and associated signalling machinery of each receptor
system have been examined in detail, only the role of integrins
incellmigrationhasbeenconclusively established.Conversely,
the functions of syndecans, DDRs and CD44 in the different
types of cell migration, their integration into distinct adhesion
and de-adhesion functions of the cell, their functional overlap
and their spatiotemporal coordination during cell-matrix
interaction and migration within multi-ligand enviroments
remain unknown. Syndecans and DDRs cooperate with
integrins synergistically in mediating cell adhesion and
migration; this compromises defined experimental control of
their functions. In order to experimentally overcome the
governance of integrins and to gain better conceptual insights
into each adhesion system independently, future strategies will
require models of limited integrin availablility or integrin
deficiency. Integrin-deficient cell models that still retain their
cytoskeletal and polarization machinery will be instrumental in
addressing specific migration modes and mechanisms and their
response to physical tissue properties. To this end, the
discrimination of the bona fide adhesion function of DDRs,
syndecans and CD44 from their other co-receptor functions and
from intracellular docking to cytoskeletal and signalling
scaffolds, which contribute to cell adhesion and migration by
indirect routes, will be of importance. Such approaches will
clarify the way that distinct adhesion systems spatiotemorally
contribute to the complex process of cell dynamics and of
anchoring in multifaceted tissue environments.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Abdulhussein R, McFadden C, Fuentes-Prior P, Vogel WF (2004)
Exploring the collagen-binding site of the DDR1 tyrosine kinase
receptor. J Biol Chem 279:31462–31470
Cell Tissue Res (2010) 339:83–92 89AhrensT,SleemanJP,SchemppCM,HowellsN,HofmannM,PontaH,
Herrlich P, Simon JC (2001) Soluble CD44 inhibits melanoma
tumorgrowthbyblockingcellsurface CD44binding to hyaluronic
acid. Oncogene 20:3399–3408
Alves F, Saupe S, Ledwon M, Schaub F, Hiddemann W, Vogel WF
(2001) Identification of two novel, kinase-deficient variants of
discoidin domain receptor 1: differential expression in human
colon cancer cell lines. FASEB J 15:1321–1323
Ballestrem C, Hinz B, Imhof BA, Wehrle-Haller B (2001) Marching at
the front and dragging behind: differential alphaVbeta3-integrin
turnover regulates focal adhesion behavior. J Cell Biol 155:1319–
1332
Banerji S, Wright AJ, Noble M, Mahoney DJ, Campbell ID, Day AJ,
Jackson DG (2007) Structures of the Cd44-hyaluronan complex
provide insight into a fundamental carbohydrate-protein interac-
tion. Nat Struct Mol Biol 14:234–239
Bazil V, Horejsi V (1992) Shedding of the CD44 adhesion molecule
from leukocytes induced by anti-CD44 monoclonal antibody
simulating the effect of a natural receptor ligand. J Immunol
149:747–753
Beauvais DM, Burbach BJ, Rapraeger AC (2004) The syndecan-1
ectodomain regulates alphavbeta3 integrin activity in human
mammary carcinoma cells. J Cell Biol 167:171–181
BendallLJ,Nilsson SK,Khan NI,JamesA,Bonnet C, Lock RB, PapaR,
Bradstock KF, Gottlieb DJ (2004) Role of CD44 variant exon 6 in
acute lymphoblastic leukaemia: association with altered bone
marrow localisation and increased tumour burden. Leukemia
18:1308–1311
Beningo KA, Hamao K, Dembo M, Wang YL, Hosoya H (2006)
Traction forces of fibroblasts are regulated by the Rho-dependent
kinase but not by the myosin light chain kinase. Arch Biochem
Biophys 456:224–231
Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum
J, Zako M (1999) Functions of cell surface heparan sulfate
proteoglycans. Annu Rev Biochem 68:729–777
Blaser H, Reichman-Fried M, Castanon I, Dumstrei K, Marlow FL,
Kawakami K, Solnica-Krezel L, Heisenberg CP, Raz E (2006)
Migration of zebrafish primordial germ cells: a role for myosin
contraction and cytoplasmic flow. Dev Cell 11:613–627
Bourguignon LY (2008) Hyaluronan-mediated CD44 activation of
RhoGTPase signaling and cytoskeleton function promotes tumor
progression. Semin Cancer Biol 18:251–259
Bourguignon LY, Zhu H, Shao L, Chen YW (2000) CD44 interaction
with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated
breast tumor cell migration. J Biol Chem 275:1829–1838
Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung
MC (2001) Hyaluronan promotes CD44v3-Vav2 interaction with
Grb2–p185(HER2) and induces Rac1 and Ras signaling during
ovarian tumor cell migration and growth. J Biol Chem
276:48679–48692
Brown TA, Bouchard T, St John T, Wayner E, Carter WG (1991)
Human keratinocytes express a new CD44 core protein (CD44E)
as a heparan-sulfate intrinsic membrane proteoglycan with
additional exons. J Cell Biol 113:207–221
Buday L, Wunderlich L, Tamas P (2002) The Nck family of adapter
proteins: regulators of actin cytoskeleton. Cell Signal 14:723–731
Burbach BJ, Ji Y, Rapraeger AC (2004) Syndecan-1 ectodomain
regulates matrix-dependent signaling in human breast carcinoma
cells. Exp Cell Res 300:234–247
Burridge K, Chrzanowska-Wodnicka M (1996) Focal adhesions,
contractility, and signaling. Annu Rev Cell Dev Biol 12:463–518
Carragher NO, Walker SM, Scott Carragher LA, Harris F, Sawyer TK,
Brunton VG, Ozanne BW, Frame MC (2006) Calpain 2 and Src
dependence distinguishes mesenchymal and amoeboid modes of
tumour cell invasion: a link to integrin function. Oncogene
25:5726–5740
Chalkiadaki G, Nikitovic D, Berdiaki A, Sifaki M, Krasagakis K,
Katonis P, Karamanos NK, Tzanakakis GN (2009) Fibroblast
growth factor-2 modulates melanoma adhesion and migration
through a syndecan-4-dependent mechanism. Int J Biochem Cell
Biol 41:1323–1331
Chen Z, Zhuo W, Wang Y, Ao X, An J (2008) Down-regulation of
layilin, a novel hyaluronan receptor, via RNA interference,
inhibits invasion and lymphatic metastasis of human lung A549
cells. Biotechnol Appl Biochem 50:89–96
Choi S, Kim Y, Park H, Han IO, Chung E, Lee SY, Kim YB, Lee JW,
Oh ES, Yi JY (2009) Syndecan-2 overexpression regulates
adhesion and migration through cooperation with integrin alpha2.
Biochem Biophys Res Commun 384:231–235
Cooke ME, Sakai T, Mosher DF (2000) Contraction of collagen
matrices mediated by alpha2beta1A and alpha(v)beta3 integrins.
J Cell Sci 113:2375–2383
Curat CA, Eck M, Dervillez X, Vogel WF (2001) Mapping of epitopes
in discoidin domain receptor 1 critical for collagen binding. J
Biol Chem 276:45952–45958
Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A (1998)
Remodeling of collagen matrix by human tumor cells requires
activation and cell surface association of matrix
metalloproteinase-2. Cancer Res 58:3743–3750
DiMilla PA, Barbee K, Lauffenburger DA (1991) Mathematical model
for the effects of adhesion and mechanics on cell migration
speed. Biophys J 60:15–37
Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F,
Detmar M, Goetinck P (2001) Delayed wound repair and
impaired angiogenesis in mice lacking syndecan-4. J Clin Invest
107:R9–R14
Entschladen F, Niggemann B, Zanker KS, Friedl P (1997) Differential
requirement of protein tyrosine kinases and protein kinase C in
the regulation of T cell locomotion in three-dimensional collagen
matrices. J Immunol 159:3203–3210
Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z (2008) Collective
epithelial migration and cell rearrangements drive mammary
branching morphogenesis. Dev Cell 14:570–581
Fackler OT, Grosse R (2008) Cell motility through plasma membrane
blebbing. J Cell Biol 181:879–884
Friedl P (2004) Prespecification and plasticity: shifting mechanisms of
cell migration. Curr Opin Cell Biol 16:14–23
Friedl P, Brocker EB (2000) The biology of cell locomotion within three-
dimensional extracellular matrix. Cell Mol Life Sci 57:41–64
Friedl P, Gilmour D (2009) Collective cell migration in morphogen-
esis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445–457
Friedl P, Weigelin B (2008) Interstitial leukocyte migration and
immune function. Nat Immunol 9:960–969
Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity
and escape mechanisms. Nat Rev Cancer 3:362–374
Friedl P, Wolf K (2009) Plasticity of cell migration modes—a multi-
scale tuning model. J Cell Biol (in press)
Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zanker KS
(1997) Migration of highly aggressive MV3 melanoma cells in 3-
dimensional collagen lattices results in local matrix reorganiza-
tion and shedding of alpha2 and beta1 integrins and CD44.
Cancer Res 57:2061–2070
Friedl P, Entschladen F, Conrad C, Niggemann B, Zanker KS (1998)
CD4+ T lymphocytes migrating in three-dimensional collagen
lattices lack focal adhesions and utilize beta1 integrin-
independent strategies for polarization, interaction with collagen
fibers and locomotion. Eur J Immunol 28:2331–2343
Friedl P, Borgmann S, Brocker EB (2001) Amoeboid leukocyte
crawling through extracellular matrix: lessons from the Dictyos-
telium paradigm of cell movement. J Leukoc Biol 70:491–509
Friedl P, Hegerfeldt Y, Tusch M (2004) Collective cell migration in
morphogenesis and cancer. Int J Dev Biol 48:441–449
90 Cell Tissue Res (2010) 339:83–92Goebeler M, Kaufmann D, Brocker EB, Klein CE (1996) Migration of
highly aggressive melanoma cells on hyaluronic acid is associ-
ated with functional changes, increased turnover and shedding of
CD44 receptors. J Cell Sci 109:1957–1964
Goodison S, Urquidi V, Tarin D (1999) CD44 cell adhesion
molecules. Mol Pathol 52:189–196
Grinnell F (2008) Fibroblast mechanics in three-dimensional collagen
matrices. J Bodyw Mov Ther 12:191–193
Grinnell F (2009) Cell migration and signaling in three-dimensional
matrix. Annu Rev Cell Dev Biol (in press)
Hegerfeldt Y, Tusch M, Brocker EB, Friedl P (2002) Collective cell
movement in primary melanoma explants: plasticity of cell-cell
interaction, beta1-integrin function, and migration strategies.
Cancer Res 62:2125–2130
Heino J, Kapyla J (2009) Cellular receptors of extracellular matrix
molecules. Curr Pharm Des 15:1309–1317
Hienola A, Tumova S, Kulesskiy E, Rauvala H (2006) N-syndecan
deficiency impairs neural migration in brain. J Cell Biol
174:569–580
Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and
migration. Nat Rev Cancer 2:91–100
Hou G, Vogel WF, Bendeck MP (2002) Tyrosine kinase activity of
discoidin domain receptor 1 is necessary for smooth muscle cell
migration and matrix metalloproteinase expression. Circ Res
90:1147–1149
HumphriesMJ(2000)Integrinstructure.BiochemSocTrans28:311–339
Humphries MJ, McEwan PA, Barton SJ, Buckley PA, Bella J, Mould AP
(2003) Integrin structure: heady advances in ligand binding, but
activation still makes the knees wobble. Trends Biochem Sci
28:313–320
Huttenlocher A, Sandborg RR, Horwitz AF (1995) Adhesion in cell
migration. Curr Opin Cell Biol 7:697–706
Hynes RO (1992) Integrins: versatility, modulation, and signaling in
cell adhesion. Cell 69:11–25
Hynes RO (2002) Integrins: bidirectional, allosteric signaling
machines. Cell 110:673–687
Iozzo RV (1998) Matrix proteoglycans: from molecular design to
cellular function. Annu Rev Biochem 67:609–652
Iwanicki MP, Vomastek T, Tilghman RW, Martin KH, Banerjee J,
Wedegaertner PB, Parsons JT (2008) FAK, PDZ-RhoGEF and
ROCKII cooperate to regulate adhesion movement and trailing-
edge retraction in fibroblasts. J Cell Sci 121:895–905
Jacobson K, O'Dell D, Holifield B, Murphy TL, August JT (1984)
Redistribution of a major cell surface glycoprotein during cell
movement. J Cell Biol 99:1613–1623
Kamohara H, Yamashiro S, Galligan C, Yoshimura T (2001)
Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes
migration of leukocytes in three-dimensional collagen lattices.
FASEB J 15:2724–2726
Khotskaya YB, Dai Y, Ritchie JP, Macleod V, Yang Y, Zinn K,
Sanderson RD (2009) Syndecan-1 is required for robust growth,
vascularization and metastasis of myeloma tumors in vivo. J Biol
Chem 284:26085-26095
Koo DH, McFadden C, Huang Y, Abdulhussein R, Friese-Hamim M,
Vogel WF (2006) Pinpointing phosphotyrosine-dependent inter-
actions downstream of the collagen receptor DDR1. FEBS Lett
580:15–22
Lammermann T, Sixt M (2009) Mechanical modes of “amoeboid” cell
migration. Curr Opin Cell Biol 21:636–644
Lammermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Soldner
R, Hirsch K, Keller M, Forster R, Critchley DR, Fassler R, Sixt
M (2008) Rapid leukocyte migration by integrin-independent
flowing and squeezing. Nature 453:51–55
Larsen M, Artym VV, Green JA, Yamada KM (2006) The matrix
reorganized: extracellular matrix remodeling and integrin signal-
ing. Curr Opin Cell Biol 18:463–471
Lee JH, Park H, Chung H, Choi S, Kim Y, Yoo H, Kim TY, Hann HJ,
Seong I, Kim J, Kang KG, Han IO, Oh ES (2009) Syndecan-2
regulates the migratory potential of melanoma cells. J Biol Chem
284:27167–27175
Legg JW, Lewis CA, Parsons M, Ng T, Isacke CM (2002) A novel
PKC- regulated mechanism controls CD44 ezrin association and
directional cell motility. Nat Cell Biol 4:399–407
Maaser K, Wolf K, Klein CE, Niggemann B, Zanker KS, Brocker EB,
Friedl P (1999) Functional hierarchy of simultaneously expressed
adhesion receptors: integrin alpha2beta1 but not CD44 mediates
MV3 melanoma cell migration and matrix reorganization within
three-dimensional hyaluronan-containing collagen matrices. Mol
Biol Cell 10:3067–3079
Midwood KS, Valenick LV, Hsia HC, Schwarzbauer JE (2004)
Coregulation of fibronectin signaling and matrix contraction
by tenascin-C and syndecan-4. Mol Biol Cell 15:5670–
5677
Midwood KS, Mao Y, Hsia HC, Valenick LV, Schwarzbauer JE (2006)
Modulation of cell-fibronectin matrix interactions during tissue
repair. J Invest Dermatol Symp Proc 11:73–78
Morgan MR, Humphries MJ, Bass MD (2007) Synergistic control of
cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol
8:957–969
Moser M, Legate KR, Zent R, Fassler R (2009) The tail of integrins,
talin, and kindlins. Science 324:895–899
Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P,
Iwatsubo T, Nakajima M, Shinohara M, Saya H (2004) Cell-
matrix interaction via CD44 is independently regulated by
different metalloproteinases activated in response to extracel-
lular Ca(2+) influx and PKC activation. J Cell Biol 165:893–
902
Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function,
and association with the malignant process. Adv Cancer Res
71:241–319
Naor D, Nedvetzki S, Walmsley M, Yayon A, Turley EA, Golan I,
Caspi D, Sebban LE, Zick Y, Garin T, Karussis D, Assayag-
Asherie N, Raz I, Weiss L, Slavin S, Golan I (2007) CD44
involvement in autoimmune inflammations: the lesson to be
learned from CD44-targeting by antibody or from knockout
mice. Ann N Y Acad Sci 1110:233–247
Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV (2008)
Involvement of CD44, a molecule with a thousand faces, in
cancer dissemination. Semin Cancer Biol 18:260–267
Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H (2002)
CD44 is required for two consecutive steps in HGF/c-Met
signaling. Genes Dev 16:3074–3086
Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH (2007)
In vivo evidence for the role of CD44s in promoting breast
cancer metastasis to the liver. Am J Pathol 171:2033–2039
Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF
(1997) Integrin-ligand binding properties govern cell migration
speed through cell-substratum adhesiveness. Nature 385:537–540
Paluch E, Gucht J van der, Sykes C (2006) Cracking up: symmetry
breaking in cellular systems. J Cell Biol 175:687–692
Park H, Kim Y, Lim Y, Han I, Oh ES (2002) Syndecan-2 mediates
adhesion and proliferation of colon carcinoma cells. J Biol Chem
277:29730–29736
Peterson RM, Yu Q, Stamenkovic I, Toole BP (2000) Perturbation of
hyaluronan interactions by soluble CD44 inhibits growth of
murine mammary carcinoma cells in ascites. Am J Pathol
156:2159–2167
Petrie RJ, Doyle AD, Yamada KM (2009) Random versus direction-
ally persistent cell migration. Nat Rev Mol Cell Biol 10:538–549
Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion
molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33–
45
Cell Tissue Res (2010) 339:83–92 91Protin U, Schweighoffer T, Jochum W, Hilberg F (1999) CD44-
deficient mice develop normally with changes in subpopulations
and recirculation of lymphocyte subsets. J Immunol 163:4917–
4923
Rabinovitz I, Mercurio AM (1997) The integrin alpha6beta4 functions
in carcinoma cell migration on laminin-1 by mediating the
formation and stabilization of actin-containing motility struc-
tures. J Cell Biol 139:1873–1884
Ram R, Lorente G, Nikolich K, Urfer R, Foehr E, Nagavarapu U
(2006) Discoidin domain receptor-1a (DDR1a) promotes glioma
cell invasion and adhesion in association with matrix
metalloproteinase-2. J Neurooncol 76:239–248
Rilla K, Tiihonen R, Kultti A, Tammi M, Tammi R (2008) Pericellular
hyaluronan coat visualized in live cells with a fluorescent probe
is scaffolded by plasma membrane protrusions. J Histochem
Cytochem 56:901–910
Sanchez-Madrid F, Pozo MA del (1999) Leukocyte polarization in cell
migration and immune interactions. EMBO J 18:501–511
Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ,
Johnson KR (2008) Collagen I-mediated up-regulation of N-
cadherin requires cooperative signals from integrins and dis-
coidin domain receptor 1. J Cell Biol 180:1277–1289
Singleton PA, Bourguignon LY (2004) CD44 interaction with ankyrin
and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca
2
+ signaling leading to nitric oxide production and endothelial cell
adhesion and proliferation. Exp Cell Res 295:102–118
Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajoohesh-Ganji A, Pal-
Ghosh S, Brown M, Aquino C, Schwartz AM, Goldberger O,
Hinkes MT, Bernfield M (2002) Defects in keratinocyte
activation during wound healing in the syndecan-1-deficient
mouse. J Cell Sci 115:4517–4531
Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8:215
Tanabe KK, Ellis LM, Saya H (1993) Expression of CD44R1
adhesion molecule in colon carcinomas and metastases. Lancet
341:725–726
Tkachenko E, Rhodes JM, Simons M (2005) Syndecans: new kids on
the signaling block. Circ Res 96:488–500
Tkachenko E, Elfenbein A, Tirziu D, Simons M (2006) Syndecan-4
clustering induces cell migration in a PDZ-dependent manner.
Circ Res 98:1398–1404
Trepat X, Wasserman MR (2009) Physical forces during collective cell
migration. Nat Physics 5:426–430
van der Flier A, Sonnenberg A (2001) Function and interactions of
integrins. Cell Tissue Res 305:285–298
Vicente-Manzanares M, Choi CK, Horwitz AR (2009) Integrins in cell
migration–the actin connection. J Cell Sci 122:199–206
Vogel W (1999) Discoidin domain receptors: structural relations and
functional implications. FASEB J 13 (Suppl):S77–S82
Vogel W, Gish GD, Alves F, Pawson T (1997) The discoidin domain
receptor tyrosine kinases are activated by collagen. Mol Cell
1:13–23
Vogel WF, Abdulhussein R, Ford CE (2006) Sensing extracellular
matrix: an update on discoidin domain receptor function. Cell
Signal 18:1108–1116
Wagner W, Wein F, Roderburg C, Saffrich R, Diehlmann A, Eckstein
V, Ho AD (2008) Adhesion of human hematopoietic progenitor
cells to mesenchymal stromal cells involves CD44. Cells Tissues
Organs 188:160–169
Wallach-Dayan SB, Grabovsky V, Moll J, Sleeman J, Herrlich P, Alon R,
Naor D (2001) CD44-dependent lymphoma cell dissemination: a
cell surface CD44 variant, rather than standard CD44, supports in
vitro lymphoma cell rolling on hyaluronic acid substrate and its in
vivo accumulation in the peripheral lymph nodes. J Cell Sci
114:3463–3477
Wang SJ, Wong G, Heer AM de, Xia W, Bourguignon LY (2009)
CD44 variant isoforms in head and neck squamous cell
carcinoma progression. Laryngoscope 119:1518–1530
Wolf K, Friedl P (2009) Mapping proteolytic cancer cell-
extracellular matrix interfaces. Clin Exp Metastasis 26:289–
298
Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl
P (2007) Multi-step pericellular proteolysis controls the transition
from individual to collective cancer cell invasion. Nat Cell Biol
9:893–904
Wu ZL, Zhang L, Yabe T, Kuberan B, Beeler DL, Love A, Rosenberg
RD (2003) The involvement of heparan sulfate (HS) in FGF1/
HS/FGFR1 signaling complex. J Biol Chem 278:17121–17129
Yoshimura T, Matsuyama W, Kamohara H (2005) Discoidin domain
receptor 1: a new class of receptor regulating leukocyte-collagen
interaction. Immunol Res 31:219–230
Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B (2007)
Functional atlas of the integrin adhesome. Nat Cell Biol 9:858–867
Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H,
Kamm RD, Wells A, Lauffenburger DA, Matsudaira P (2006)
Migration of tumor cells in 3D matrices is governed by matrix
stiffness along with cell-matrix adhesion and proteolysis. Proc
Natl Acad Sci USA 103:10889–10894
Zamir E, Geiger B (2001) Molecular complexity and dynamics of cell-
matrix adhesions. J Cell Sci 114:3583–3590
Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML,
Demetriou A, Wu GD (2006) The role of the hyaluronan receptor
CD44 in mesenchymal stem cell migration in the extracellular
matrix. Stem Cells 24:928–935
Zimmerman E, Geiger B, Addadi L (2002) Initial stages of cell-matrix
adhesion can be mediated and m o d u l a t e db yc e l l - s u r f a c e
hyaluronan. Biophys J 82:1848–1857
92 Cell Tissue Res (2010) 339:83–92